ClinConnect ClinConnect Logo
Search / Trial NCT06510296

Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease

Launched by MONTEFIORE MEDICAL CENTER · Jul 15, 2024

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new digital program designed to help Black and Hispanic patients who have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. The goal is to see if this program can help patients manage their emotional well-being and, in turn, improve their physical health. Researchers know that stress and anxiety can make IBD symptoms worse, and they want to explore how a digital mind-body intervention can make a positive difference for those who are experiencing psychological distress.

To participate in the trial, you need to be at least 18 years old, identify as Black or Hispanic, and have a diagnosis of Crohn's disease or ulcerative colitis. You should also be experiencing some level of psychological distress. Participants will engage with the digital program, which aims to improve their mental health and overall quality of life. This research is particularly important because it seeks to ensure that resources are accessible to everyone, especially those from underrepresented communities who may face barriers to getting mental health support. If you meet the eligibility criteria and are interested, this could be a great opportunity to contribute to important research while potentially benefiting your own health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age ≥ 18 years
  • self-identify as Black/African American and/or Hispanic/Latino(a/x)
  • diagnosed with Crohn's disease or ulcerative colitis
  • ability to provide informed consent in English
  • elevated psychological distress: at least one T-score within 2.5 standard deviations above the mean -- NIH Toolbox Perceived Stress Scale or in the domains of either Anxiety or Depression on the NIH PROMIS-29.
  • Exclusion Criteria:
  • Anxiety, depression, or perceived stress T-scores above 2.5 standard deviations above the mean.
  • Current suicidality, past suicide attempt, or psychiatric hospitalization.

About Montefiore Medical Center

Montefiore Medical Center is a leading academic medical institution located in the Bronx, New York, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a principal sponsor of clinical studies, Montefiore fosters a collaborative environment that connects researchers, healthcare professionals, and patients to explore cutting-edge therapies and improve health outcomes. With a strong emphasis on patient-centered care, the center integrates its extensive clinical expertise with robust research capabilities to address a wide range of medical conditions, contributing significantly to the advancement of medical science and clinical practice.

Locations

Bronx, New York, United States

Patients applied

0 patients applied

Trial Officials

Ruby Greywoode, MD

Principal Investigator

Montefiore Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported